Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rotstein

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2014
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapyRobert L Carruthers, Dalia L Rotstein, Brian C Healy, et al.
Neurology|November 7, 2019
MS risk in immigrants in the McDonald era: A population-based study in Ontario, CanadaDalia L Rotstein, Ruth Ann Marrie, Colleen Maxwell, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 1, 1997
Surgical salvage after radiotherapy for advanced laryngopharyngeal carcinomaJ Davidson, T Keane, D Brown, et al.
Frontiers in Neurology|April 16, 2026
Identifying strategies to characterize the diversity of the MS population in Canada: a nominal group studyRuth Ann Marrie, Afolasade Fakolade, Colleen J Maxwell, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 23, 2026
Setting priorities for how future research in multiple sclerosis in Canada considers equity, diversity and inclusion: A modified e-Delphi studyRuth Ann Marrie, Afolasade Fakolade, Colleen J Maxwell, et al.
Head & Neck|May 1, 1995
Benign parotid adenomas: a review of the Princess Margaret Hospital experienceF F Liu, L Rotstein, A J Davison, et al.
Multiple Sclerosis and Related Disorders|July 2, 2026
The many faces of the multiple sclerosis population in CanadaRuth Ann Marrie, Chiara Gottheil, Afolasade Fakolade, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2024
Is there a prodrome to NMOSD? An investigation of neurologic symptoms preceding the first NMOSD attackSydney Lee, Ruth Ann Marrie, Giulia Fadda, et al.
Surgery, Gynecology & Obstetrics|December 1, 1983
The effect of radiofrequency hyperthermia and chemotherapy upon human neoplasms when used with adjuvant metronidazoleR E Falk, F L Moffat, K Calhoun, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2015
Effect of vitamin D on MS activity by disease-modifying therapy classDalia L Rotstein, Brian C Healy, Muhammad T Malik, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2014
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapyRobert L Carruthers, Dalia L Rotstein, Brian C Healy, et al.
Neurology|November 7, 2019
MS risk in immigrants in the McDonald era: A population-based study in Ontario, CanadaDalia L Rotstein, Ruth Ann Marrie, Colleen Maxwell, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 1, 1997
Surgical salvage after radiotherapy for advanced laryngopharyngeal carcinomaJ Davidson, T Keane, D Brown, et al.
Frontiers in Neurology|April 16, 2026
Identifying strategies to characterize the diversity of the MS population in Canada: a nominal group studyRuth Ann Marrie, Afolasade Fakolade, Colleen J Maxwell, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 23, 2026
Setting priorities for how future research in multiple sclerosis in Canada considers equity, diversity and inclusion: A modified e-Delphi studyRuth Ann Marrie, Afolasade Fakolade, Colleen J Maxwell, et al.
Head & Neck|May 1, 1995
Benign parotid adenomas: a review of the Princess Margaret Hospital experienceF F Liu, L Rotstein, A J Davison, et al.
Multiple Sclerosis and Related Disorders|July 2, 2026
The many faces of the multiple sclerosis population in CanadaRuth Ann Marrie, Chiara Gottheil, Afolasade Fakolade, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2024
Is there a prodrome to NMOSD? An investigation of neurologic symptoms preceding the first NMOSD attackSydney Lee, Ruth Ann Marrie, Giulia Fadda, et al.
Surgery, Gynecology & Obstetrics|December 1, 1983
The effect of radiofrequency hyperthermia and chemotherapy upon human neoplasms when used with adjuvant metronidazoleR E Falk, F L Moffat, K Calhoun, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2015
Effect of vitamin D on MS activity by disease-modifying therapy classDalia L Rotstein, Brian C Healy, Muhammad T Malik, et al.
Pageof 7